Skip to content

Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability

Arthroscopic Electrothermal Capsulorrhaphy, ETAC, Versus Open Inferior Capsular Shift, ICS in Patients With Shoulder Instability: A Multicentre Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00251160
Enrollment
58
Registered
2005-11-09
Start date
1999-12-31
Completion date
2010-02-28
Last updated
2015-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Dislocation

Keywords

Multi-directional instability, MDI, Ligamentous laxity, Multi-directional laxity, MDL-AII, Shoulder instability, electrothermal capsulorrhaphy, ETAC, inferior capsular shift, ICS, capsular redundancy

Brief summary

This trial will compare the effectiveness of electrothermal arthroscopic capsulorrhaphy (ETAC) to the current reference standard procedure, open inferior capsular shift (ICS), for the treatment of shoulder instability caused by ligamentous capsular redundancy. Multi-directional instability (MDI) and multi-directional laxity with anteroinferior instability (MDL-AII) are the two types of shoulder instabilities included in this trial. Hypothesis: There is no difference in disease-specific quality of life between patients undergoing an ETAC versus an open ICS for the treatment of shoulder instability caused by capsular ligamentous redundancy.

Detailed description

The shoulder is the most frequently dislocated joint in the body. Multiple causes and pathologies account for the various types of shoulder instability. Multi-directional instability (MDI) and multi-directional laxity with anteroinferior instability (MDL-AII) are similar in pathology, less common and more difficult to treat. These types of shoulder instability are caused by ligamentous capsular redundancy. When non-operative management fails for these patients, their quality of life is significantly impaired and surgical treatment is required to tighten the loose ligaments and joint capsule. A new way to treat these patients involves arthroscopic thermal shrinkage of the tissue to tighten the joint. However, there is a lack of scientific evidence to support the use of this technique called, electrothermal arthroscopic capsulorrhaphy (ETAC). The current reference (gold) standard treatment for these patients is an open inferior capsular shift (ICS) procedure. Therefore, this trial will compare the effectiveness of these surgical techniques (ETAC vs. ICS) in patients with MDI and MDL-AII by determining patient related quality of life. This study is designed as a multicentre, randomized controlled trial. Patients diagnosed with either MDI or MDL-AII who failed standardized non-operative management will undergo a diagnostic shoulder arthroscopy, and if appropriate, will be subsequently randomized in the operating room to either an ETAC or ICS surgical procedure. Computer-generated, stratified block randomization is used. Stratification is based on two variables: 1. surgeon - to account for any differences between surgeons, and 2. diagnosis (MDI or MDL-AII) - to account for any differences in the severity of pathology. The disease-specific quality of life is assessed using a validated questionnaire, the Western Ontario Shoulder Instability Index, measured at baseline, and 3, 6, 12 and 24 months. The WOSI index has 21 questions, divided into four categories to assess physical symptoms, sport/recreation/work, lifestyle and emotions. Each question is scored out of 100 using a visual analog scale response format. A lower score reflects a better quality of life.

Interventions

PROCEDUREElectrothermal arthroscopic capsulorrhaphy (ETAC)

The Oratec Vulcan Generator electro-thermal system (Oratec Interventions Inc., Menlo Park, CA, USA) delivers heat at 75C and 40 watts. An anterior portal is established above the superior border of the subscapularis tendon. For MDI patients, the heat probe is introduced through the posterior portal. The capsule is shrunk using a grid pattern until excess volume is diminished. The extent of the heat probe application is identical to the landmarks used for the open ICS. Care is taken to avoid applying heat to the capsule in the region from 5-7 o'clock within 1cm of the glenoid rim to avoid the axillary nerve. The method of heat application utilizes a grid pattern, which is less likely to cause dissolution of the capsule and subsequent catastrophic capsular loss.

PROCEDUREOpen inferior capsular shift (ICS)

MDI: lateral capsule released antero-superiorly from rotator interval to equator, posteriorly on the humeral neck. MDL-AII: release from the rotator interval to 7 o'clock (Right) or 5 o'clock (Left) position on humeral neck, to tighten the 2 bands of the inferior GH ligaments, middle GH ligament and rotator interval. Bone adjacent to the articular surface on the surgical neck of the humerus is roughened to create a bleeding bony bed. With the arm in 0deg flexion, 30deg abduction, 30deg external rotation, the inferior leaflet of the capsule is shifted superiorly and slightly laterally, and sutured to the rim of the capsule using a non-absorbable suture. Superior leaflet is shifted inferiorly and sutured. Subscapularis is repaired at its anatomic length using interrupted sutures.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
The Arthritis Society, Canada
CollaboratorOTHER
Smith and Nephew (formerly Oratec Interventions)
CollaboratorUNKNOWN
University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ages 14 years or greater * Diagnosis of MDI or MDL-AII. Diagnosis will require two or more of the following: * Symptomatic translation (pain or discomfort) in one or more directions: anterior, inferior and/or posterior; * Ability to elicit unwanted glenohumeral translations that reliably produce symptoms with one of the following tests: the anterior and posterior apprehension tests, the anterior and posterior load and shift tests, the fulcrum test, the relocation test, the Fukuda test, and/or the push-pull or stress test with the patient supine; * Presence of a positive sulcus sign of 1 centimetre or greater gap that reproduces the patient's clinical symptoms of instability and should be both palpable and visible; * Symptoms of instability: subluxation or dislocation. * Written informed consent * Failed at least 6 months of non-operative treatment * Confirmed capsular-ligamentous redundancy as determined by diagnostic arthroscopy examination.

Exclusion criteria

* Neurologic disorder (ie: axillary nerve injury; syringomyelia) * Cases involving third party compensation * Patients with primary posterior instability * A bony abnormality (Hill Sachs/bony Bankart) on standard series of x-rays consisting of a minimum of an anteroposterior view, lateral in the scapular plane and an axillary view * Presence of a Bankart lesion on arthroscopic exam of the joint * Presence of an unstable biceps anchor (ie: superior labral anterior and posterior \[SLAP\] lesion) on arthroscopic exam of the joint * Presence of a full-thickness rotator cuff tear.

Design outcomes

Primary

MeasureTime frame
Western Ontario Shoulder Instability (WOSI) IndexBaseline, 3, 6, 12, 24 months post-operatively

Secondary

MeasureTime frame
Constant score (European Shoulder Society)Baseline, 3, 6, 12, 24 months post-operatively
Recurrent instabilityUp to 24 months post-operatively
ComplicationsIntra-operatively and up to 8 weeks post-operatively
Operative timeDay of surgery
American Shoulder and Elbow Surgeon's Score (ASES)Baseline, 3, 6, 12, 24 months post-operatively

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026